UB Paderborn / Katalog / Suche / in CDI

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

International journal of cardiology. Heart & vasculature, 2018-12, Vol.21, p.11-15

2018

Volltextzugriff (PDF)

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

Europace (London, England), 2018-05, Vol.20 (5), p.731-732an

2018

Volltextzugriff (PDF)

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

Clinical research in cardiology, 2022-01, Vol.111 (1), p.70-84

2022

Volltextzugriff (PDF)

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden

International journal of cardiology. Heart & vasculature, 2020-08, Vol.29, p.100610-100610, Article 100610

Dan, Gheorghe-Andrei

2020

Volltextzugriff (PDF)

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

European journal of heart failure, 2015-06, Vol.17 (6), p.570-582

2015

Volltextzugriff (PDF)

Prognostic roles of neutrophil–lymphocyte, monocyte-lymphocyte and platelet-lymphocyte ratios for long-term all-cause mortality in heart failure

International journal of cardiology. Heart & vasculature, 2024-10, Vol.54, p.101502, Article 101502

2024

Volltextzugriff (PDF)

The wearable cardioverter-defibrillator: current technology and evolving indications

Europace (London, England), 2017-03, Vol.19 (3), p.335-345

2017

Volltextzugriff (PDF)

Polypill revisited – Unity in diversity

International journal of cardiology. Heart & vasculature, 2020-08, Vol.29, p.100607-100607, Article 100607

2020

Volltextzugriff (PDF)

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy

European heart journal supplements, 2022-06, Vol.24 (Suppl D), p.D1-D2

Dan, Gheorghe-Andrei

2022

Volltextzugriff (PDF)

Implications of geographical variation on clinical outcomes of cardiovascular trials

The American heart journal, 2012-09, Vol.164 (3), p.303-312

2012

Volltextzugriff (PDF)

The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm

International journal of cardiology, 2018-09, Vol.267, p.77-78

Dan, Gheorghe-Andrei

2018

Volltextzugriff (PDF)

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey

Journal of arrhythmia, 2020-10, Vol.36 (5), p.863-873

2020

Volltextzugriff (PDF)

Thyroid hormones and the heart

Heart failure reviews, 2016-07, Vol.21 (4), p.357-359

Dan, Gheorghe-Andrei

2016

Volltextzugriff (PDF)

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Europace (London, England), 2015-12, Vol.17 (12), p.1777-1786

2015

Volltextzugriff (PDF)

Acute rate control in atrial fibrillation: an urgent need for the clinician

European heart journal supplements, 2022-06, Vol.24 (Suppl D), p.D3-D10

2022

Volltextzugriff (PDF)

'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry

Europace (London, England), 2016-05, Vol.18 (5), p.648-657

2016

Volltextzugriff (PDF)

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)

Europace (London, England), 2019-10, Vol.21 (10), p.1603-1604

2019

Volltextzugriff (PDF)

Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients

Scandinavian cardiovascular journal : SCJ, 2021-07, Vol.55 (4), p.227-236

2021

Volltextzugriff (PDF)

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey

International journal of cardiology. Heart & vasculature, 2020-02, Vol.26, p.100461-100461, Article 100461

2020

Volltextzugriff (PDF)

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Europace (London, England), 2015-08, Vol.17 (8), p.1169-1196

2015

Volltextzugriff (PDF)

Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry

International journal of cardiology, 2018-11, Vol.271, p.68-74

2018

Volltextzugriff (PDF)

Contemporary management of patients with syncope in clinical practice: an EHRA physician-based survey

Europace (London, England), 2020-06, Vol.22 (6), p.980-987

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden

Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation

Prognostic roles of neutrophil–lymphocyte, monocyte-lymphocyte and platelet-lymphocyte ratios for long-term all-cause mortality in heart failure

The wearable cardioverter-defibrillator: current technology and evolving indications

Polypill revisited – Unity in diversity

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy

Implications of geographical variation on clinical outcomes of cardiovascular trials

The net clinical benefit of the antithrombotic protection in prosthetic mechanical valves: Changing the paradigm

Treatment implications of renal disease in patients with atrial fibrillation: The BALKAN‐AF survey

Thyroid hormones and the heart

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry

Acute rate control in atrial fibrillation: an urgent need for the clinician

'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry

Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry

Contemporary management of patients with syncope in clinical practice: an EHRA physician-based survey

Aktive Filter

Suchergebnisse filtern